Disorders currently under investigation with deep brain stimulation
Disorder | Circuit | Postulated circuit dysfunction | DBS target(s) being studied or that could be considered | Stage of study |
Parkinson disease, essential tremor or dystonia | Motor | - Beta and theta oscillations - GPi overactivity - STN overactivity - Neuronal bursting | STN, GPi, GPe, VL thalamus, PPN and spinal cord | Standard of care |
Major depression | Limbic | - Increased activity in OFC, SCC, amygdala and VS - Failure to downregulate amygdalar activation | SCC, NAcc, habenula and medial forebrain bundle | Phase III |
Obsessive–compulsive disorder | Motor and limbic | - OFC hyperactivity - Failure of VS-mediated thalamofrontal inhibition | NAcc, BNST, ITP, ALIC and STN | Phase II/III |
Tinnitus | Auditory | - Sensory deafferentation - Thalamocortical dysrhythmia | Auditory pathways and caudate nucleus | Phase I |
Tourette syndrome | Motor and limbic | - Overactive direct pathway - Failure of thalamocortical inhibition | GPi and CM–Pf | Phase I |
Schizophrenia — positive symptoms | Executive function, cognition and reward | - Thalamocortical dysrhythmia - Failure of saliency networks | Temporal cortex and NAcc | Preclinical |
Schizophrenia — negative symptoms | Motivation, reward, cognition and mood | - Mesolimbic and mesocortical dysfunction - Failure to engage anticipatory hedonic system | NAcc, VTA and SCC | Preclinical |
Alzheimer disease | Cognitive and memory circuits | - Amyloid-β plaques throughout the brain - Default mode network dysfunction - Cholinergic degeneration - Entorhinal cortex and hippocampal atrophy | Fornix, entorhinal cortex, hippocampus, cingulate, precuneus, frontal cortex and nucleus basalis | Phase II/III |
Pain (phantom pain, deafferentation pain, central pain and nociceptive pain) | Sensory systems and interoceptive awareness | - Sensory deafferentation - Abnormal neuronal spontaneous bursting behaviour | Sensory pathways, periventricular and periaqueductal areas, cingulate and insula | Phase I/II |
Addiction | Reward | NAcc sensitivity to reward | NAcc | Phase I/II |
Anorexia nervosa | Reward and mood | - Frontoparietal disconnection - Parietal hypometabolism - Insular abnormality - SCC overactivity | SCC and NAcc | Phase II |
Epilepsy | Various | Abnormal excitability and synchrony | CM thalamus, anterior thalamic nucleus, thalamus and seizure focus | Phase II/III |
- ALIC, anterior limb of the capsula interna; BNST, bed nucleus of stria terminalis; CM, centromedian; CM–Pf, CM–parafascicular; GPe, globus pallidus externus; GPi, globus pallidus internus; ITP, inferior thalamic peduncle; NAcc, nucleus accumbens; OFC, orbitofrontal cortex; PPN, pedunculopontine nucleus; SCC, subgenual cingulate cortex; STN, subthalamic nucleus; VL, ventral lateral; VS, ventral striatum; VTA, ventral tegmental area.
Target
Indication | Deep brain targets |
Parkinson’s disease | Globus pallidus interna, subthalamic nucleus |
Dystonia | Globus pallidus interna |
Tremor | Ventralis intermedius thalamic nucleus, zona incerta |
Depression | Subgenual cingulate cortex, anterior limb of internal capsule |
Obsessive-compulsive disorder | Anterior limb of internal capsule |
Tourette’s syndrome | Ventromedial thalamus, anterior limb of internal capsule, globus pallidus interna |
Epilepsy | Anterior thalamic nucleus, centromedian thalamic nucleus |
Cluster headache | Posterior hypothalamus |
- Reference: FitzGerald 2018
- VIM: coordinates atlas
- Medial-laterally (X)
- 14-15 mm from the medial line or
- 11-11.5 mm from the wall of the third ventricle;
- Anteroposteriorly (Y)
- 3-7 mm anterior to the PC, or
- 3-4 mm posterior to the mid-commissural point;
- Midpoint (Z) at the AC-PC line
- GPi
- Intercommissural (AC-PC) line
- 19–21 mm laterally from the midline
- 2.5 mm in front of the AC-PC midpoint
- 5 mm below the AC-PC line
- STN
- X = 11mm
- Y = − 2.5mm
- Z = − 4.5mm
Pedunculopontine nucleus (PPN)
- Upper pons in the dorsolateral portion of the ponto-mesencephalic tegmentum. Its main mass is positioned at the trochlear nucleus level, and is part of the mesenphalic locomotor region (MLR) in the upper brainstem.
- In PD patients, GABAergic BG output levels are abnormally increased, and gait disturbances are produced via abnormal increases in SNr-induced inhibition of the MLR.
- Good DBS target for Gait and freezing